What is CervoMed Inc. (CRVO) stock price today?

CervoMed Inc. (CRVO) currently trades at $3.69 per share. The stock has a market capitalization of $35.92M and a P/E ratio of —x.

Is CRVO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, CervoMed Inc. has a Smart Value Score of 22/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is —.

What is CervoMed Inc.'s revenue and earnings?

CervoMed Inc. has trailing twelve-month (TTM) revenue of $4.01M with profit margins of 0.00%. Earnings per share (EPS) is $-2.98.

Is CervoMed Inc. financially healthy?

CervoMed Inc.'s Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of — places it in the —.

CRVO

CervoMed Inc.

NASDAQ: CRVO · HEALTHCARE · BIOTECHNOLOGY

$3.69

+1.10% today

Updated 2026-04-30

Market cap

$35.92M

P/E ratio

—

P/S ratio

8.97x

EPS (TTM)

$-2.98

Dividend yield

—

52W range

$4 – $12

Volume

0.1M

Market cap

$35.92M

P/E ratio

—

P/S ratio

8.97x

EPS (TTM)

$-2.98

Dividend yield

—

52W range

$4 – $12

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

6.0

Quality

2.5

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$22.14

+500.00%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy8 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-6.58M

- Revenue declining -99.60% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$7.14M	$9.74M	$4.01M	$4.01M
Net income	$-15.59M	$-2.17M	$-16.29M	$-26.97M	$-8.09M
EPS	—	—	—	—	$-2.98
Free cash flow	$-2.57M	$-7.45M	$-16.53M	$-23.45M	$-6.58M
Profit margin	—	-30.40%	-167.29%	-673.06%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CRVO	$35.92M	22	3.7	2.5	5.0	6.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

CervoMed Inc. trades at $3.69. Our Smart Value Score of 22/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $4.01M.

Frequently asked questions

What is CervoMed Inc.'s stock price?

CervoMed Inc. (CRVO) trades at $3.69.

Is CervoMed Inc. overvalued?

Smart Value Score 22/100 (Grade F, Strong Sell).

What is the price target of CervoMed Inc. (CRVO)?

The analyst target price is $22.14, representing +500.0% upside from the current price of $3.69.

What is CervoMed Inc.'s revenue?

TTM revenue is $4.01M.

Piotroski F-Score?

3/9 — weak financial health.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.cervomed.com

Quick metrics

P/S ratio8.97x

ROE-93.90%

Beta-5.04

50D MA$4.18

200D MA$7.07

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CRVO vs LLY →CRVO vs JNJ →CRVO vs ABBV →Stock screener →